News und Analysen
Vertex Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Vertex Pharmaceuticals Incorporated? Here are five stocks we like better.
- Vertex reported strong Q2 growth: Revenue rose 12% year over year to $3.3 billion, prompting
Vertex Q2 Earnings Call Highlights
Key Points
- Interested in Vertex, Inc.? Here are five stocks we like better.
- Strong Q2 profitability: Revenue increased 10.5% year over year to $204 million, while adjusted EBITDA rose 33% to $51
Stoke Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Stoke Therapeutics, Inc.? Here are five stocks we like better.
- EMPEROR remains on schedule: Stoke completed enrollment ahead of plan with 162 Dravet syndrome patients
Merck Spotlights Weekly HIV Treatment, Monthly PrEP as $5B Growth Opportunity
Key Points
- Interested in Merck & Co., Inc.? Here are five stocks we like better.
- Merck reported positive Phase III results for its once-weekly oral islatravir/lenacapavir HIV regimen, showing
EQS-Adhoc: Fresenius Medical Care AG : Fresenius Medical Care verzeichnet in Q2 2026 ein operatives Ergebnis ohne Sondereffekte über den Markterwartungen und bestätigt den Ausblick für das Gesamtjahr 2026
Bayer Aktie: Zwei Katalysatoren, eine Woche
Die Bayer-Aktie rutscht am Montag um 2,21 Prozent auf 47,42 Euro ab. Auf 30-Tage-Sicht…
Der Beitrag Bayer Aktie: Zwei Katalysatoren, eine Woche erschien zuerst auf kapitalmarktexperten.de.
Quelle ka
Stryker Aktie: 3,69 Dollar schlägt Schätzung, Guidance enttäuscht
Stryker hat gerade eine Lektion erteilt, die diese Berichtssaison im Medtech-Sektor unangenehm vertraut wirkt:…
Der Beitrag Stryker Aktie: 3,69 Dollar schlägt Schätzung, Guidance enttäuscht erschien
Bayer Aktie: 7,25-Milliarden-Vergleich am 19. August
Für Bayer beginnt eine Woche, die über die weitere Kursrichtung entscheiden könnte. Am Dienstag…
Der Beitrag Bayer Aktie: 7,25-Milliarden-Vergleich am 19. August erschien zuerst auf kapitalmarktexpe
Stryker Aktie: Guidance-Enttäuschung trotz Gewinnsprung
Stryker legt bessere Zahlen vor als erwartet – und die Aktie bricht trotzdem ein.…
Der Beitrag Stryker Aktie: Guidance-Enttäuschung trotz Gewinnsprung erschien zuerst auf kapitalmarktexperten.de.
Qu
Stryker Q2 Earnings Call Highlights
Key Points
- Interested in Stryker Corporation? Here are five stocks we like better.
- Stryker reported strong Q2 results, with 9% organic sales growth and adjusted EPS of $3.69, up 17.9% year
Proto Labs Q2 Earnings Call Highlights
Key Points
- Interested in Proto Labs, Inc.? Here are five stocks we like better.
- Record revenue and stronger profitability: Proto Labs reported Q2 revenue of $149.3 million, up 10.2% year over
AbbVie Q2 Earnings Call Highlights
Key Points
- Interested in AbbVie Inc.? Here are five stocks we like better.
- AbbVie exceeded Q2 expectations, reporting nearly $17 billion in revenue, up 10.2% year over year, and adjusted EPS of
Cigna Group Q2 Earnings Call Highlights
Key Points
- Interested in Cigna Group? Here are five stocks we like better.
- Cigna raised its 2026 adjusted EPS outlook to at least $30.45 after second-quarter revenue reached $71.7 billion and
DexCom Q2 Earnings Call Highlights
Key Points
- Interested in DexCom, Inc.? Here are five stocks we like better.
- DexCom’s Q2 revenue rose 13% year over year to $1.31 billion, driven by continued CGM demand, new-customer starts
WAVE Life Sciences Q2 Earnings Call Highlights
Key Points
- Interested in WAVE Life Sciences Ltd.? Here are five stocks we like better.
- WAVE Life Sciences reported weaker financial results: Q2 revenue fell to $2.3 million from $8.7 million
Regeneron Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Regeneron Pharmaceuticals, Inc.? Here are five stocks we like better.
- Regeneron delivered strong second-quarter growth: Revenue rose 17% year over year to $4.3 billion
Sanofi Q2 Earnings Call Highlights
Key Points
- Interested in Sanofi? Here are five stocks we like better.
- Sanofi raised its 2026 outlook after second-quarter sales rose 17.8% to €11.6 billion and business EPS increased 33.3%
Humana Q2 Earnings Call Highlights
Key Points
- Interested in Humana Inc.? Here are five stocks we like better.
- Humana expects 2027 Medicare Advantage margin expansion to keep it on track for a sustainable pretax margin of at least
Europäische Kommission genehmigt Marktzulassung des an XFG angepassten COVID-19-Impfstoffs von Pfizer und BioNTech in der Europäischen Union
- Daten zeigten, dass die COVID-19-Impfstoffformulierung für das Jahr 2026-2027, die gegen die XFG-Variante gerichtet ist, eine starke Immunantwort gegen derzeit zirkulierende und neu auftretende
Bausch + Lomb Q2 Earnings Call Highlights
Key Points
- Interested in Bausch + Lomb Corporation? Here are five stocks we like better.
- Bausch + Lomb reported strong second-quarter results, with revenue up 8% year over year on a
Biogen Q2 Earnings Call Highlights
Key Points
- Interested in Biogen Inc.? Here are five stocks we like better.
- Biogen’s second-quarter revenue rose 3% to $2.7 billion, driven by growth products and the newly acquired Apellis
AbbVie Aktie: RINVOQ punktet doppelt
Zwei EU-Zulassungen an einem Tag — das gab es für AbbVie selten. Die Europäische…
Der Beitrag AbbVie Aktie: RINVOQ punktet doppelt erschien zuerst auf kapitalmarktexperten.de.
Quelle kapitalmarktexp
CSL feiert Fertigstellung des ersten Schiffes der weltweit führenden Umschlagflotte für das Simandou-Projekt
MONTREAL, July 29, 2026 (GLOBE NEWSWIRE) -- Die CSL-Gruppe („CSL“), ein weltweit führender Anbieter von verantwortungsbewussten Seetransportdienstleistungen, gibt die Auslieferung der MV Wontanara
IQVIA Q2 Earnings Call Highlights
Key Points
- Interested in IQVIA Holdings Inc.? Here are five stocks we like better.
- IQVIA exceeded Q2 expectations, with revenue up 8.7% to $4.368 billion, adjusted EBITDA rising 9.2% to $994
GSK Q2 Earnings Call Highlights
Key Points
- Interested in GSK PLC Sponsored ADR? Here are five stocks we like better.
- GSK reported solid second-quarter results, with sales up 5% to more than £8.4 billion, core operating profit




